Perrigo Company PLC reached the end of the first year of marketing its first Rx-to-OTC switch with the sixth approval for additional packaging options for the product, OTC Nasonex 24HR Allergy nasal spray.
The Dublin-based firm’s latest approval for the mometasone furoate, 50-mcg metered spray, from the US Food and Drug Administration came on
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?